Markets › India › NSE › ANTHEM

Anthem Biosciences Ltd

NSE:ANTHEMHealthcareNSE:CNX500NSE:NIFTY500_EW

₹808.50−1.66%At closeAt close · Mon 19 Oct · ≈ AED 31.24 · Market cap $4.87B · Next earnings Wed 2 Dec

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	47.0%	47.0%	42.5%	35.6%	59.7%	42.1%	—	—
Operating margin	—	41.3%	35.2%	30.5%	32.1%	32.9%	32.9%	+0.0 pts
Net margin	32.9%	32.9%	36.4%	25.9%	24.5%	27.9%	27.9%	+0.0 pts
EBITDA margin	46.0%	46.0%	41.2%	36.3%	41.0%	39.3%	—	—
Return on equity	—	29.9%	22.1%	19.1%	18.7%	19.5%	19.5%	+0.0 pts
Return on assets	25.1%	25.1%	19.1%	15.3%	16.1%	17.3%	17.3%	+0.0 pts
Return on capital employed	—	36.5%	20.1%	21.0%	23.9%	22.5%	—	—
Debt / equity	—	0.0×	0.1×	0.1×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	2.3%	2.3%	6.3%	9.9%	4.0%	1.6%	—	—
Interest coverage	0.0×	50.5×	55.0×	45.4×	59.1×	101.5×	—	—
Current ratio	—	4.8×	8.1×	4.4×	5.3×	5.5×	5.5×	+0.0%
Quick ratio	—	4.6×	7.3×	3.7×	4.3×	5.2×	—	—
Cash ratio	—	1.5×	2.1×	0.5×	1.0×	0.8×	0.8×	+0.0%
Asset turnover	0.8×	0.8×	0.5×	0.6×	0.7×	0.6×	—	—
Inventory turnover	—	10.9×	4.6×	4.1×	2.2×	9.9×	—	—
Receivables turnover	—	3.7×	3.8×	2.9×	4.0×	3.6×	—	—
Dividend payout	—	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.